Krebs Biochemicals & Industries Limited (KREBSBIO.NS)
INR 77.62
(-4.71%)
INR 77.62
(-4.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -108.74 Million INR | -22.16% |
| 2022 | 264.56 Million INR | 227.45% |
| 2021 | -207.59 Million INR | -52.35% |
| 2020 | -136.25 Million INR | -46.09% |
| 2019 | -93.26 Million INR | -427.87% |
| 2018 | -17.66 Million INR | -252.11% |
| 2017 | -5.01 Million INR | -188.92% |
| 2016 | 5.64 Million INR | 112.6% |
| 2015 | -44.78 Million INR | -399.33% |
| 2014 | -8.96 Million INR | 0.0% |
| 2012 | -1.39 Million INR | -100.46% |
| 2011 | 302.17 Million INR | 108.55% |
| 2010 | 144.89 Million INR | -7.92% |
| 2009 | 157.35 Million INR | 36.27% |
| 2008 | 115.48 Million INR | -41.24% |
| 2007 | 196.52 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 56.91 Million INR | 229.17% |
| 2023 Q4 | 35.33 Million INR | -36.04% |
| 2023 Q3 | 55.24 Million INR | -56.96% |
| 2023 FY | 205.93 Million INR | -22.16% |
| 2023 Q1 | 102.16 Million INR | 22.92% |
| 2023 Q2 | 128.36 Million INR | 25.65% |
| 2022 Q1 | -25.45 Million INR | 52.26% |
| 2022 Q3 | 74.61 Million INR | -1.27% |
| 2022 Q4 | 83.1 Million INR | 11.38% |
| 2022 FY | 264.56 Million INR | 227.45% |
| 2022 Q2 | 75.57 Million INR | 396.91% |
| 2021 Q4 | -53.31 Million INR | 30.78% |
| 2021 FY | -207.59 Million INR | -52.35% |
| 2021 Q1 | -37.75 Million INR | -62.13% |
| 2021 Q3 | -77.02 Million INR | -95.05% |
| 2021 Q2 | -39.49 Million INR | -4.6% |
| 2020 Q2 | -39.97 Million INR | -26.25% |
| 2020 Q4 | -23.28 Million INR | 43.67% |
| 2020 Q1 | -31.65 Million INR | -3.34% |
| 2020 FY | -136.25 Million INR | -46.09% |
| 2020 Q3 | -41.34 Million INR | -3.43% |
| 2019 Q4 | -30.63 Million INR | -53.27% |
| 2019 FY | -93.26 Million INR | -427.87% |
| 2019 Q1 | -22.1 Million INR | -264.39% |
| 2019 Q3 | -19.98 Million INR | 2.69% |
| 2019 Q2 | -20.54 Million INR | 7.08% |
| 2018 FY | -17.66 Million INR | -252.11% |
| 2018 Q1 | -10.32 Million INR | -174.5% |
| 2018 Q4 | -6.06 Million INR | 40.12% |
| 2018 Q3 | -10.13 Million INR | -214.5% |
| 2018 Q2 | 8.84 Million INR | 185.7% |
| 2017 FY | -5.01 Million INR | -188.92% |
| 2017 Q4 | 13.85 Million INR | -82.1% |
| 2017 Q3 | 77.4 Million INR | 4672.44% |
| 2017 Q2 | 1.62 Million INR | 108.96% |
| 2017 Q1 | -18.1 Million INR | -222.98% |
| 2016 Q1 | -6.83 Million INR | 57.59% |
| 2016 Q4 | 14.72 Million INR | 261.31% |
| 2016 Q3 | -9.12 Million INR | -340.75% |
| 2016 Q2 | -2.07 Million INR | 69.69% |
| 2016 FY | 5.64 Million INR | 112.6% |
| 2015 Q4 | -16.11 Million INR | -73.13% |
| 2015 Q3 | -9.3 Million INR | -79.98% |
| 2015 Q2 | -5.17 Million INR | -1061.15% |
| 2015 Q1 | 538 Thousand INR | 108.3% |
| 2015 FY | -44.78 Million INR | -399.33% |
| 2014 Q1 | - INR | 0.0% |
| 2014 FY | -8.96 Million INR | 0.0% |
| 2014 Q4 | -6.48 Million INR | -161.01% |
| 2014 Q3 | -2.48 Million INR | -49560.0% |
| 2014 Q2 | -5000.00 INR | 0.0% |
| 2013 Q4 | - INR | 100.0% |
| 2013 Q2 | 59.67 Million INR | 0.0% |
| 2013 Q3 | -112 Thousand INR | -100.19% |
| 2012 FY | -1.39 Million INR | -100.46% |
| 2012 Q2 | 18.16 Million INR | 0.0% |
| 2012 Q3 | -8.58 Million INR | -147.28% |
| 2011 Q4 | 98.02 Million INR | 33.28% |
| 2011 Q2 | 67.32 Million INR | 0.0% |
| 2011 FY | 302.17 Million INR | 108.55% |
| 2011 Q3 | 73.55 Million INR | 9.25% |
| 2010 FY | 144.89 Million INR | -7.92% |
| 2009 FY | 157.35 Million INR | 36.27% |
| 2008 Q4 | 289.8 Million INR | 0.0% |
| 2008 FY | 115.48 Million INR | -41.24% |
| 2007 FY | 196.52 Million INR | 0.0% |
| 2007 Q4 | 38.63 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | 196.212% |
| Aarti Drugs Limited | 8.31 Billion INR | 101.308% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 101.865% |
| Ajanta Pharma Limited | 21.06 Billion INR | 100.516% |
| Alembic Limited | 1 Billion INR | 110.874% |
| Alkem Laboratories Limited | 52.29 Billion INR | 100.208% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 100.406% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 101.748% |
| Bal Pharma Limited | 770.19 Million INR | 114.119% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | 966.855% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 102.943% |
| Brooks Laboratories Limited | 65.62 Million INR | 265.722% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | 124.051% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 101.181% |
| Divi's Laboratories Limited | 32.44 Billion INR | 100.335% |
| Eris Lifesciences Limited | 10.42 Billion INR | 101.043% |
| Granules India Limited | 16.79 Billion INR | 100.647% |
| Ind-Swift Limited | 2.17 Billion INR | 105.006% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 116.664% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 100.713% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 100.554% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | 117.526% |
| Medicamen Biotech Limited | 495.49 Million INR | 121.947% |
| Medico Remedies Limited | 262.14 Million INR | 141.484% |
| Wockhardt Limited | 7.72 Billion INR | 101.409% |
| Orchid Pharma Limited | 2.32 Billion INR | 104.687% |
| RPG Life Sciences Limited | 2.48 Billion INR | 104.38% |
| Shilpa Medicare Limited | 3.56 Billion INR | 103.053% |
| Sigachi Industries Limited | 2 Billion INR | 105.431% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 93.433% |
| Unichem Laboratories Limited | 4.86 Billion INR | 102.235% |
| Vaishali Pharma Limited | 90.32 Million INR | 220.398% |
| Wanbury Limited | 1.73 Billion INR | 106.284% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 100.087% |
| FDC Limited | 6.58 Billion INR | 101.651% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 105.193% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 107.389% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 100.066% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 100.875% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 102.631% |
| Laurus Labs Limited | 15.44 Billion INR | 100.704% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | 115.733% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 102.255% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | 120.552% |
| Hester Biosciences Limited | 1.27 Billion INR | 108.538% |
| Ipca Laboratories Limited | 48.58 Billion INR | 100.224% |
| Venus Remedies Limited | 2.18 Billion INR | 104.982% |
| ZIM Laboratories Limited | 1.26 Billion INR | 108.578% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 100.099% |
| Morepen Laboratories Limited | 6.16 Billion INR | 101.765% |
| Neuland Laboratories Limited | 8.24 Billion INR | 101.318% |
| Sequent Scientific Limited | 2.97 Billion INR | 103.651% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 102.637% |
| Valiant Laboratories Limited | 138.02 Million INR | 178.786% |
| Windlas Biotech Limited | 1.33 Billion INR | 108.123% |
| Hikal Limited | 5.95 Billion INR | 101.825% |
| Innova Captab Limited | 3.46 Billion INR | 103.139% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 101.881% |
| Themis Medicare Limited | 2.42 Billion INR | 104.494% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 102.304% |
| Mankind Pharma Limited | 42.19 Billion INR | 100.258% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 100.157% |
| Sakar Healthcare Limited | 699.58 Million INR | 115.545% |
| Albert David Limited | 1.4 Billion INR | 107.723% |
| Lupin Limited | 125.09 Billion INR | 100.087% |
| Gufic Biosciences Limited | 4.07 Billion INR | 102.669% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 100.042% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 105.763% |
| Syncom Formulations (India) Limited | 559.5 Million INR | 119.436% |
| Piramal Enterprises Limited | 8.04 Billion INR | 101.352% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 100.233% |
| NATCO Pharma Limited | 25.73 Billion INR | 100.423% |
| Suven Life Sciences Limited | -200.79 Million INR | 45.842% |
| Strides Pharma Science Limited | 14.38 Billion INR | 100.756% |
| Indoco Remedies Limited | 8.04 Billion INR | 101.352% |
| Alpa Laboratories Limited | 188.89 Million INR | 157.57% |
| Lasa Supergenerics Limited | 121.02 Million INR | 189.851% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | 127.808% |